Percorso Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Percorso Life Sciences's estimated annual revenue is currently $1.4M per year.
- Percorso Life Sciences's estimated revenue per employee is $155,000
Employee Data
- Percorso Life Sciences has 9 Employees.
- Percorso Life Sciences grew their employee count by 0% last year.
Percorso Life Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | President | Reveal Email/Phone |
Percorso Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Percorso Life Sciences?
Percorso Life Sciences is a consultative support and implementation organization which specializes in providing expert strategic, business, operational and tactical execution to providers of Life Science tools and services. Our ability to partner, advise and execute leads to successful and measurable business growth in the North American Life Science market. We accomplish this by focusing on a variety of client requirements designed to minimize financial investment and market risk. Percorso Life Sciences is able to work in a transparent partnership with clients' strategic objectives to capture and maximize value creation.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | N/A | N/A |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.7M | 9 | N/A | N/A |